Agile Therapeutics, Inc. (AGRX)
| Market Cap | 44.41M |
| Revenue (ttm) | 3.34M |
| Net Income (ttm) | -69.16M |
| Shares Out | 121.40M |
| EPS (ttm) | -0.77 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 42,215 |
| Open | 0.362 |
| Previous Close | 0.360 |
| Day's Range | 0.362 - 0.370 |
| 52-Week Range | 0.358 - 3.770 |
| Beta | 0.95 |
| Analysts | Buy |
| Price Target | 2.83 (+673.6%) |
| Earnings Date | Nov 2, 2021 |
About AGRX
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a reg...
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for AGRX stock is "Buy." The 12-month stock price forecast is 2.83, which is an increase of 673.65% from the latest price.
News
Agile Therapeutics Acknowledges New Government Guidance Reinforcing Requirement to Cover Contraceptives that a Woman ...
PRINCETON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- On January 10, 2022, the tri-agencies, Department of Labor (DOL), Health and Human Services (HHS) and Treasury issued new guidance that supports women'...
Agile Therapeutics and Afaxys Partner to Expand Access to Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal ...
PRINCETON, N.J. and CHARLESTON, S.C., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a new alliance with Afaxys Pharma, LLC to p...
Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will prese...
Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will present at...
Penny Stocks To Buy For Under $1 & What To Watch Right Now
Looking for cheap penny stocks to buy? Here are 4 to watch trading below $1 right now.
Top Penny Stocks For Your Under $1 List Right Now
Check these Under $1 penny stocks out for your watchlist The post Top Penny Stocks For Your Under $1 List Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates
Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 5.26% and -13.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Agile Therapeutics Reports Third Quarter 2021 Financial Results
Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed
Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2,...
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
Top Penny Stocks to Watch Making Big Moves Right Now
If you're making a penny stocks watchlist right now, check these three small-caps out The post Top Penny Stocks to Watch Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News and...
Best Biotech Penny Stocks on Reddit to Buy Now? 4 For Your Watchlist
Looking for biotech penny stocks to watch on Reddit? Check these four out for your list The post Best Biotech Penny Stocks on Reddit to Buy Now?
Agile Therapeutics Applauds Congressional Chairs' Letter to Biden Administration Requesting Enforcement of Contracept...
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today applauded House Congressional Committee leaders in urging the Secretaries ...
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Josephine Torrente has been appointed to the Company's boar...
Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 sh...
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it intends to offer and sell shares of its common stock and...
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021 Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021
Agile Therapeutics to Participate in Upcoming Investor Conferences
PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following v...
Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women's Access to Twirla® (levonorges...
PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth service, ...
2 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...
Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates
Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 4.76% and -18.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Agile Therapeutics: Q2 Earnings Insights
Shares of Agile Therapeutics (NASDAQ:AGRX) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 66.67% year over year to ($0.20), which beat the ...
Agile Therapeutics Reports Second Quarter 2021 Financial Results
Total Prescriptions (TRx) Grew 171% in Second Quarter
Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021
Live Conference Call and Webcast at 4:30 p.m. EDT Live Conference Call and Webcast at 4:30 p.m. EDT
Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference
PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the company will be participating virtually in the William Blair ...
Agile Therapeutics (AGRX) Reports Q1 Loss, Lags Revenue Estimates
Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 9.09% and -82.10%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?